Datavant Closes $40M Financing Round; Acquires Universal Patient Key

Datavant, a San Francisco, CA-based provider of solutions for healthcare organizations to safely link their data to improve medical research and patient care, completed $40.5m financing round.

The round was led by Roivant Sciences and Travis May.

The company also acquired Universal Patient Key (UPK), a provider of HIPAA-compliant de-identification services for healthcare data to over 70 healthcare providers, insurers, pharmacies, universities, analytics providers, government agencies, and other institutions. UPK’s clients include Allscripts, McKesson, Decision Resources Group, Optum, IBM Watson (Truven Health), Komodo Health, Prognos, Precision Health, and dozens of other companies. In conjunction with the deals, Shahir Kassam-Adams will join Datavant as Head of Strategy, and Jason LaBonte, PhD, formerly Chief Product Officer at UPK, will join Datavant as Head of Product. Joe Austin, Co-Founder and Chairman of UPK, will serve as an advisor to Datavant.

Led by Travis May, Co-Founder and Chief Executive Officer, and Eric Perakslis, PhD, Chief Scientific Officer, Datavant organizes and structures healthcare data for use in clinical trial decision-making to enable pharma companies to improve the design and interpretation of clinical trials.



Join the discussion